ImmunoCellular Therapeutics, Ltd. (IMUC) Completes Interim Analysis of ICT-107 Phase 2 Clinical Trials
ImmunoCellular Therapeutics, a clinical-stage company developing immune-based therapies for the treatment of brain and other cancers, today said that the…